Evidence map›Paper›PMID 34549113›Full record

ArticleACS omega2021

Experimental and Computational Study on the Microfluidic Control of Micellar Nanocarrier Properties.

Sima Rezvantalab, Reza Maleki, Natascha Ingrid Drude, Mohammad Khedri, Alexander Jans, Mostafa Keshavarz Moraveji, Milita Darguzyte, Ebrahim Ghasemy, Lobat Tayebi, Fabian Kiessling

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sima RezvantalabDepartment of Chemical Engineering, Urmia University of Technology, 57166-93188 Urmia, Iran.
Reza MalekiComputational Biology and Chemistry Group (CBCG), Universal Scientific Education and Research Network (USERN), Tehran 1449614535 Iran.
Natascha Ingrid DrudeInstitute for Experimental Molecular Imaging, Medical Faculty, RWTH Aachen International University, 52074 Aachen, Germany.ORCID https://orcid.org/0000-0002-7153-2894
Mohammad KhedriComputational Biology and Chemistry Group (CBCG), Universal Scientific Education and Research Network (USERN), Tehran 1449614535 Iran.
Alexander JansDWI-Leibniz Institute for Interactive Materials, Forckenbeckstr. 50, 52074 Aachen, Germany.
Mostafa Keshavarz MoravejiDepartment of Chemical Engineering, Amirkabir University of Technology (Tehran Polytechnic), 424 Hafez Avenue, Tehran 1591634311, Iran.ORCID https://orcid.org/0000-0003-4891-340X
Milita DarguzyteInstitute for Experimental Molecular Imaging, Medical Faculty, RWTH Aachen International University, 52074 Aachen, Germany.
Ebrahim GhasemyCentre Énergie Matériaux Télécommunications, Institut national de la recherché, 1650 Boul. Lionel-Boulet, Varennes, Quebec J3X 1S2, Canada.ORCID https://orcid.org/0000-0001-8509-0268
Lobat TayebiSchool of Dentistry, Marquette University, Milwaukee, Wisconsin 53233, United States.ORCID https://orcid.org/0000-0003-1947-5658
Fabian KiesslingInstitute for Experimental Molecular Imaging, Medical Faculty, RWTH Aachen International University, 52074 Aachen, Germany.ORCID https://orcid.org/0000-0002-7341-0399

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microfluidic-based synthesis is a powerful technique to prepare well-defined homogenous nanoparticles (NPs). However, the mechanisms defining NP properties, especially size evolution in a microchannel, are not fully understood. Herein, microfluidic and bulk syntheses of riboflavin (RF)-targeted poly(lactic-

Identifiers

PMID34549113
PMCPMC8444197

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.